Long COVID prevalence and physiology-centered risks: population-based study in Ukraine
Open Access
- 22 March 2023
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 31 (2) , 597-602
Abstract
Aim Multifaceted long COVID caused by SARS-COV-2 affects all populations in the World and takes priority over any other research topics for health care. The purpose of study is to identify physiology-centered risks, prevalence, symptoms and laboratory findings in patients with long COVID in Ukraine. Methods A prospective, cohort study was carried out on 332 patients with long COVID after 4 weeks and more after acute infection COVID-19 from Jul 1, 2021, to Jul 1, 2022. Physiology-centered risks related to age, gender, body mass index (BMI), marital status and educational capacity, smoking, lifestyle, physical activity, and laboratory findings (before disease), and symptom distribution were analyzed. Results The cohort for the study consisted of 166 females and 107 males (mean age = 42; including young 18 (5.4%) and middle- and old-aged adults 314 (96.4%)). Increased BMI was in 61%, and less physical activity—65%. There were 4 clusters of symptoms related to physical, neurocognitive, pulmonary, and pain conditions. 95% of participants had ≥ 3 symptoms. The most common symptoms were fatigue (90%), muscular pain (85%), anosmia (70%), hair loss (70%), sleep disorders (70%), dyspnea (30%), and brain fog (25%). Among laboratory finding increased CRP (92.6%) and fibrinogen (82.7%) dominated. There are no differences between hospitalized and non-hospitalized patients in distribution symptoms. Conclusions The prevalence of long COVID is 23%, and its physiology-centered risk factors are related to age more 38 years, female sex, unhealthy lifestyle, increased BMI, and increased inflammatory markers during COVID-19. The most common symptoms are associated with neurocognitive and pain clusters.Keywords
This publication has 18 references indexed in Scilit:
- A clinical case definition of post-COVID-19 condition by a Delphi consensusThe Lancet Infectious Diseases, 2021
- Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORTPLOS ONE, 2021
- Symptoms, complications and management of long COVID: a reviewJournal of the Royal Society of Medicine, 2021
- Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatmentsInfectious Diseases, 2021
- Where are we with drug treatments for covid-19?BMJ, 2021
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategiesClinical Medicine, 2021
- Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomesJournal of Medical Virology, 2020
- COVID-19: NEW DISEASE AND CHAOS WITH PANIC, ASSOCIATED WITH STRESSProceedings of the Shevchenko Scientific Society. Medical Sciences, 2020
- Anti‐inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulationThe Journal of Physiology, 2016